Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data

• Published in: Frontiers in immunology Vol. 15; p. 1295029
• Main Authors: Russo, Antonio, Grimaldi, Pierantonio, Pisaturo, Mariantonietta, Onorato, Lorenzo, Coppola, Nicola
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2024
• Subjects: COVID-19; early treatment; hospitalization; Immunology; monoclonal antibodies; mortality; COVID-19; mortality; hospitalization; early treatment; monoclonal antibodies

The aim of this meta-analysis was to ascertain whether sotrovimab was effective in reducing COVID-19 related hospitalization and mortality also in Omicron BA.2, BA.4 and BA.5 subvariants compared to other antivirals effective in index period. A systematic review and meta-analysis of Randomized Contr...